BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34486152)

  • 1. Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy.
    Liu L; Xie W; Song Z; Wang T; Li X; Gao Y; Li Y; Zhang J; Guo X
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):132-138. PubMed ID: 34486152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
    Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
    Wang K; Gao X; Cong H; Zhang W; Shi X; Dai S; Zhou Z
    Endocrine; 2020 Jul; 69(1):188-195. PubMed ID: 32222878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X
    Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
    Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
    Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
    Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
    Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of reference intervals for plasma metanephrines in seated position measured by LC-MS/MS and assessment of diagnostic performance in pheochromocytoma/paraganglioma.
    Lin Y; Wang M; Cao Y
    Ann Clin Biochem; 2023 May; 60(3):160-168. PubMed ID: 36653315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
    Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma.
    Bílek R; Vlček P; Šafařík L; Michalský D; Novák K; Dušková J; Václavíková E; Widimský J; Zelinka T
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31027285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Václavíková E; Widimský J
    Physiol Res; 2017 Sep; 66(Suppl 3):S397-S408. PubMed ID: 28948824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass.
    Unger N; Hinrichs J; Deutschbein T; Schmidt H; Walz MK; Mann K; Petersenn S
    Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):494-500. PubMed ID: 22696168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
    Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas.
    Wang H; Zhang X; Zhen Q; Zou W; Chen H; Luo C; Ding M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1156():122306. PubMed ID: 32829134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
    Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
    Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z
    Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
    Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
    J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
    Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
    Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High specificity of spot urinary free metanephrines in diagnosis and prognosis of pheochromocytomas and paragangliomas by HPLC with electrochemical detection.
    Zuo M; Zhen Q; Zhang X; Zou W; Yang X; Tian G; Shi Z; Li Q; Ding M
    Clin Chim Acta; 2018 Mar; 478():82-89. PubMed ID: 29273559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.